iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.190
-0.075 (-5.93%)
At close: Jul 2, 2024, 4:00 PM
1.200
+0.010 (0.84%)
After-hours: Jul 2, 2024, 7:56 PM EDT

iCAD, Inc. Market Cap

iCAD, Inc. has a market cap or net worth of $31.58 million as of July 2, 2024. Its market cap has decreased by -9.51% in one year.

Market Cap
31.58M
Enterprise Value
11.82M
1-Year Change
-9.51%
Ranking
Category
Stock Price
$1.19

Market Cap Chart

Since December 1, 1998, iCAD, Inc.'s market cap has increased from $12.80M to $31.58M, an increase of 146.74%. That is a compound annual growth rate of 3.59%.

History

DateMarket Cap% Change
Jul 1, 202433.60M-27.90%
Dec 29, 202346.60M-
Dec 30, 202246.60M-74.23%
Dec 31, 2021180.80M-40.43%
Dec 31, 2020303.50M101.80%
Dec 31, 2019150.40M142.19%
Dec 31, 201862.10M9.33%
Dec 29, 201756.80M9.44%
Dec 30, 201651.90M-36.16%
Dec 31, 201581.30M-42.95%
Dec 31, 2014142.50M12.65%
Dec 31, 2013126.50M140.04%
Dec 31, 201252.70M68.91%
Dec 30, 201131.20M-49.76%
Dec 31, 201062.10M-10.52%
Dec 31, 200969.40M35.55%
Dec 31, 200851.20M-35.92%
Dec 31, 200779.90M-26.63%
Dec 29, 2006108.90M153.26%
Dec 30, 200543.00M-71.90%
Dec 31, 2004153.00M5.66%
Dec 31, 2003144.80M119.73%
Dec 31, 200265.90M212.32%
Dec 31, 200121.10M-50.93%
Dec 29, 200043.00M35.22%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Immuneering 32.32M
Reviva Pharmaceuticals Holdings 32.20M
ImmuCell 32.03M
Quince Therapeutics 31.87M
Spectral AI 31.64M
ProMIS Neurosciences 31.48M
ReWalk Robotics 31.31M
NKGen Biotech 31.18M
Market Cap Rankings